| 0 | 💬 0 |
A phase Ib, placebo-controlled randomized clinical trial of the Ebolavirus DNA vaccine candidate INO-4201 followed by electroporation as booster vaccination in healthy, rVSVDeltaG-ZEBOV-GP-primed volunteers (Boost-EBOV).
(linkinghub.elsevier.com)
|
Clinical Microbiology and Infection 2026-01-27 | #vaccination #antibody #clinical trial #immunogenicity #ebola |